| Assessment of Fermented Dairy Products in Terms of Bioactive Compounds | Filiz YANGILAR | 109–115 |
| The Role of MMP-2 and MMP-9 in Breast Cancer | Tuba TAŞKAN,Aymelek GÖNENÇ | 116–124 |
| Alzheimer Disease and Dementia | Arda Can AYDIN | 125–136 |
| Hypericum perforatum (St John’s Wort) for Depression Treatment from Past to Present-What Do We Know? | Ezgi ERSOY,Esra EROĞLU ÖZKAN | 137–148 |
| Off-Label Drug Use in Children | N. İpek KIRMIZI,Volkan AYDIN,Narin AKICI,Ahmet AKICI | 149–157 |
| Agent with Doping Effects That are Prohibited for the Use of Athletes | Göksun DEMİREL,Derya DOĞANAY | 158–170 |
| Nail Fungal Infection (Onychomycosis) and the Methods of Increasing Usage in Topical Treatment | Esra KODAN,Ülker GÜL,Figen TIRNAKSIZ | 171–183 |
| RNA Damage and its Relationship with Pathological Conditions | Selinay Başak ERDEMLİ KÖSE,Anıl YİRÜN,Aylin BALCI,Pınar ERKEKOĞLU | 184–196 |
| The Effect of Proton Pump Inhibitors on Possible Drug Interactions and Microbiota | Fatma Betül İSPİR,Şaziye Sezin PALABIYIK YÜCELİK,TERKEN BAYDAR | 197–207 |
| Vaccine Hesitancy and Effects of COVID-19 | Pınar ERKEKOĞLU,Selinay Başak ERDEMLİ KÖSE,Aylin BALCI,Anıl YİRÜN | 208–220 |